
Tcr2 Therapeutics (TCRR)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Tcr2 Therapeutics (TCRR) Stock
Start investing in Tcr2 Therapeutics (TCRR)
About Tcr2 Therapeutics (TCRR)
Market cap | $58.11M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 679.61K |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -0.35x |
Today's range | — |
Debt / equity | — |
52 week range | $0.82 - $3.88 |
5 year debt / equity | 2.1x |
Beta (LTM) | 0.98x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | May 11, 2023 |
Dividend payable date | — |
Tcr2 Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy TCRR stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in TCRR stock
Navigate to the Explore page. Then, type TCRR into the search bar. When you see TCRR stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased TCRR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Tcr2 Therapeutics Stock Earnings
The value each TCRR share was expected to gain vs. the value that each TCRR share actually gained.
Tcr2 Therapeutics (TCRR) reported Q1 2023 earnings per share (EPS) of -$1.03, missing estimates of -$0.68 by 51.47%. In the same quarter last year, Tcr2 Therapeutics's earnings per share (EPS) was -$0.76. Tcr2 Therapeutics is expected to release next earnings on 05/11/2023, with an earnings per share (EPS) estimate of $0.